一只成功用oclacitinibmaleate治疗的猫的扩散性死性外耳炎,有两次延迟复发
1Animal Skin and Ear Specialists, Melbourne Veterinary Specialist Centre, Melbourne, VIC, Australia.
Veterinary medicine and science
|November 11, 2025
概括
本案例报告详细介绍了一只患有扩散性死性外耳炎 (PNOE) 的猫的成功治疗oclacitinib. 该研究观察到复发和自发解决,这表明oclacitinib.
科学领域:
- 兽医医学 兽医医学 兽医医学
- 皮肤病学 皮肤病学
- 药理学 药理学是指药理学的学科.
背景情况:
- 扩散性死性外耳炎 (PNOE) 是猫的严重耳部疾病.
- 对于PNOE的治疗选择可能是有限的,特别是在耐火病例中.
研究的目的:
- 为了记录oclacitinib在治疗猫类PNOE病例中的疗效.
- 调查对oclacitinib的反应,包括复发和剂量依赖的影响.
主要方法:
- 一个猫被诊断患有PNOE的单一病例报告.
- 用oclacitinib进行的治疗.
- 监测病变的解决,复发和自发愈合.
主要成果:
- 奥克拉西替尼实现了初始PNOE病变的完全缓解和第一个复发.
- 观察到两次延迟复发,第二次复发自发消失.
- 发现了对oclacitinib的潜在剂量依赖性反应.
结论:
- 奥克拉西替尼 (oclacitinib) 是一种非标签治疗猫类PNOE的有希望的药物,特别是在困难的情况下.
- 需要进一步的研究,以确定奥克拉西提尼布在PNOE的最佳剂量和长期安全性.
相关概念视频
Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Treatment Resistent Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel Disease...
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2 (COX-2),...
Tonsillitis II: Management
This lesson will focus on the different treatment options for managing tonsillitis, which typically depend on the cause and severity.
Candidiasis
Candidiasis is a fungal infection caused by opportunistic species of Candida. It can affect various anatomical sites, including the skin, oral cavity, nails, and genitourinary tract. Among its forms, vaginal candidiasis is the most common type of mucosal infection. It typically results from the overgrowth of Candida albicans in the vaginal mucosa. Under normal conditions, C. albicans exists as a commensal organism within the vaginal microbiota, regulated by the dominance of lactobacilli, which...


